Dai-Dan Co., Ltd.
Stock Price Chart
2026/10/09 12:26 UpdatedPrice Trend
2026/10/09 12:26 UpdatedPrice & Trading Details
2026/10/09 12:26 UpdatedPRICE
TRADING
Analyst Recommendations 1 analysts
Updated 2026/10/01Earnings Calendar
Updated 2026/10/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2013/02/06 | ¥1.71 | ¥1.15 | -32.6% |
| 2012/08/08 | ¥2.41 | ¥-3.19 | -232.1% |
| 2012/05/08 | ¥7.12 | ¥11.16 | +56.8% |
| 2012/02/08 | ¥1.83 | ¥-2.40 | -231.2% |
Shareholder Composition
Updated 2026/10/01Dividend History 4Years Growth
Updated 2026/10/04| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥98 | +52.3% |
| 2025 | ¥64 | +93.0% |
| 2024 | ¥33 | +81.8% |
| 2023 | ¥18 | +22.2% |
| 2022 | ¥15 | - |
Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥162,929M | ¥185,961M | ¥197,431M | ¥262,732M |
| Gross Profit | ¥20,723M | ¥22,624M | ¥26,218M | ¥41,350M |
| Operating Income | ¥7,585M | ¥8,429M | ¥10,878M | ¥23,038M |
| Pretax Income | ¥8,410M | ¥9,900M | ¥13,348M | ¥24,203M |
| Net Income | ¥5,778M | ¥6,626M | ¥9,087M | ¥17,443M |
| EPS | ¥45.03 | ¥51.59 | ¥70.70 | ¥135.61 |
| Operating Margin | 4.66% | 4.53% | 5.51% | 8.77% |
| Balance Sheet | ||||
| Total Assets | ¥139,099M | ¥148,544M | ¥160,553M | ¥215,309M |
| Total Equity | ¥77,080M | ¥82,241M | ¥93,754M | ¥107,018M |
| Total Liabilities | ¥62,019M | ¥66,303M | ¥66,799M | ¥108,291M |
| Cash | ¥16,065M | ¥25,379M | ¥22,696M | ¥51,761M |
| Interest-bearing Debt | ¥3,904M | ¥3,621M | ¥3,157M | ¥23,602M |
| Equity Ratio | 55.41% | 55.36% | 58.39% | 49.70% |
| D/E Ratio | 0.05 | 0.04 | 0.03 | 0.22 |
| Cash Flow | ||||
| Operating CF | -¥11,718M | ¥15,941M | ¥596M | ¥12,402M |
| Investing CF | -¥873M | -¥4,729M | -¥603M | -¥832M |
| Financing CF | -¥3,214M | -¥2,218M | -¥2,829M | ¥16,044M |
| Free CF | -¥12,939M | ¥14,132M | -¥1,030M | ¥12,060M |
| Efficiency | ||||
| ROE | 7.50% | 8.06% | 9.69% | 16.30% |
| ROA | 4.15% | 4.46% | 5.66% | 8.10% |
Latest IR Information
-
Q1 FY2027 Earnings Explanation Materials
Consolidated earnings summary for the first quarter of FY2027 disclosed. Segment indicators such as completion work and order book by segment, trends in sales and profits, net assets and equity ratio, and other financial metrics are disclosed. Progress toward the...
Read more -
2027 Fiscal Year Q1 Financial Summary (Consolidated) [Japanese GAAP]
Sales were 61,601 million yen, YoY +2.4%; operating income 10,932 million yen (+12.7%); ordinary income 11,292 million yen (+12.2%); net income attributable to owners of the parent was 6,571 million yen (down 4.6%). Full-year guidance unchanged, dividend guidance continued as...
Read more -
Notice of Dividend (Increase in Dividend)
Daiden announced an increase in the year-end dividend for fiscal year ending March 2026 to 56 yen per share, with an expected total annual dividend of 250 yen after the stock split.
Read more -
【Daidan】 Announcement of Executive Personnel Changes | June 26, 2026
Daidan Corporation has decided on executive personnel changes ahead of the June 26, 2026 shareholders' meeting, announcing new and reappointed director candidates. Masatoshi Nakazawa is scheduled to be appointed as a new director.
Read more -
Fiscal Year Ending March 2026 Financial Summary
Completed construction revenue of 256,228 million yen (YoY -2.5%), Operating profit of 34,479 million yen (up 49.7% YoY), Order backlog of 353,102 million yen (up 25.5% YoY), End-of-term construction backlog of 355,273 million yen (up 37.5% YoY)
Read more -
【Daidan】2026 Financial Results｜Revenue of 256.2 billion yen, Net profit of 26.7 billion yen achieved
Daidan achieved sales of 256.2 billion yen, operating income of 34.4 billion yen, and net income attributable to owners of parent of 26.7 billion yen for the fiscal year ending March 2026. While sales decreased by 2.5% compared to the...
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥4,400
Rating Score: 1.00 (Based on 1 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Dai-Dan Co., Ltd. engages in the design, supervision, and construction of electrical, air conditioning, water hygiene, and firefighting facilities works and machinery in Japan. The company offers Hot Cure, a hospital room for immunocompromised patients; All-in-one CP unit, a cell culture processing facility; air conditioning system for hybrid operating room; MonoBooker, a system which makes the location of temporary equipment visible; brightness design solutions; CV4D, a Construction Visualizer 4D for field survey support; artificial intelligence solutions; REMOVIS, a building monitoring and management solutions; ZEB, which reduces energy consumption in buildings; and Enefice Kyushu, Enefice Shikoku, and Enefice Hokkaido buildings. It also provides iLac system, a breeding rack for experimental animals; Air Barrier Booth, a cross-contamination prevention system; Karatto Operation, air-conditioning system for operating rooms; air purification and negative pressure unit; sputum collection booth; Lami Flowrack system; and Barrier Smart, a room pressure control system. In addition, the company offers WIT WET, vaporization type humidification system; air filter regeneration; airflow analysis solutions; quick covers; lightweight reinforced ducts; heat storage tanks; Virtual Duct Clean Room system; FlowSmart technology; Cushion Ducky, an anti-corrosion technology; anticorrosion diagnostic technology; dehumidification system; and radiant and floor mounted air conditioning solutions. Further, it engages in contract manufacturing of pharmaceuticals. Dai-Dan Co., Ltd. was founded in 1903 and is headquartered in Osaka, Japan.
